MiNK Therapeutics, Inc. (INKT)
NASDAQ: INKT · Real-Time Price · USD
0.690
-0.020 (-2.79%)
Nov 21, 2024, 3:55 PM EST - Market closed
MiNK Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
31
Market Cap
27.29M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | - | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | 689.63K | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Nortech Systems | 135.57M |
ImmuCell | 23.84M |
Surrozen | 10.00M |
DURECT | 8.59M |
Daré Bioscience | 1.88M |
Longeveron | 1.85M |
Pluri | 598.00K |
GlycoMimetics | 10.00K |
INKT News
- 7 days ago - MiNK Therapeutics, Inc. (INKT) Q3 2024 Earnings Conference Call Transcript - Seeking Alpha
- 10 days ago - MiNK Therapeutics to Provide Corporate Update and Third Quarter 2024 Financial Report - GlobeNewsWire
- 14 days ago - MiNK's iNKT Cell Therapy Shows Potential for Optimal Multi-Combination for Resistant Solid Cancers at SITC 2024 - GlobeNewsWire
- 21 days ago - MiNK Therapeutics Announces Appointment of Dr. Robert Kadlec to Board of Directors - GlobeNewsWire
- 6 weeks ago - MiNK Therapeutics and Autonomous Therapeutics Announce Collaboration to Develop Novel Therapies Targeting Metastatic Tumors - GlobeNewsWire
- 6 weeks ago - MiNK Therapeutics to Present Data From iNKT Cell Programs at SITC 2024 - GlobeNewsWire
- 2 months ago - MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference - GlobeNewsWire
- 3 months ago - MiNK Therapeutics, Inc. (INKT) Q2 2024 Earnings Call Transcript - Seeking Alpha